Day Two
DAY ONE

Tuesday 29 January 2002

08.45 Chairman’s Opening Welcome
Falk Strascheg, Founder and Managing Partner, Extorel
09.00 State of the European Private Equity Market
Frank Brechlin, Private Equity Advisor, Bank Vontobel AG
09.20 Key Investment Themes in 2002
Stephen Murphy , Managing Director
Schroder Salomon Smith Barney
09.40 The Biotech Sector – Recent Trends in Financing
Franc Gregori, Head of Pharmaceutical, Healthcare and BioTech Research,
BNP Paribas
10.00

The Impact of Genomics on Drug Discovery & Development
Dr. Ismail Kola, Vice President, Discovery Research and Global Head: Genomics Sciences & Pharmacogenomics, Pharmacia Corporation

10.20 The IPO Market in Europe: Quo Vadis?
Frances Bornstein, Deputy Head SWX New Market, SWX Swiss Exchange
10.40

Break

  Chair Dr. Christian Zschocke, Managing Partner, Morgan Lewis & Bockius
11.00 Emerging Business Markets
David McKenzie,, Business Development Executive, IBM NetGeneration
11.20 M&A – Mission Critical in Early Stage VC
Friedrich Bornikoel, Managing Partner,
TVM Techno Venture Management
11.40 Analysing Europe: The Next Major Developments
Toon den Heijer, Executive Director, Gilde IT Fund
12.00 Business Process Integration - One Next Big Thing
Dr. Hans-Dieter Koch, CEO, b-business partners
12.20 Maturation of Entrepreneurship in Europe: Building Block for the Establishment of a Sophisticated VC Environment in Europe
Mr Eric Achtmann, Partner, PolyTechnos Venture-Partners
12.40 Lunch
 
BIOTECH
Chair Franc Gregori, BNP Paribas
WIRELESS PANEL
Chair Oliver Haeggberg,
T-Venture
14.00
Dr
CEO
14.20
Strat
Man
Dr
and
Nov
14.40–
15.25

Business Models for CAT and Biotech
Dr. David Chiswell, CEO,
Cambridge Antibody Trust

Biopartnering and Technology Transfer as Strategic Success Factors in the Management of Innovation
Dr. Romeo Paioni, Head of Scientific and External Affairs,
Novartis Pharma AG
BIOTECH PANEL
Prof. Dr. Horst Domdey
,
CEO, Bio-M AG
Steve Burrill,
CEO, Burrill & Co
Dr. Jörg Neermann,
Managing Partner,
DVC Deutsche Venture Capital
Dr. Dietrich Ulmer,
CEO & President,

Siemens Mobile Acceleration (smac)
Kaj-Erik Relander,
General Partner Europe,

Accel Partners
Dr. Christian Reitberger,
Assistant Director,

Apax Partners
Jean Schmitt,
Partner

Sofinnova Partners
15.30

STREAMED COMPANY PRESENTATION WORKSHOPS
Featuring up to 60 Start-Up – Pre-IPO Companies

BIOTECH / MEDTECH

WIRELESS

SOFTWARE /ASP
BIOTECH / MEDTECH

E-COMMERCE
& INTERNET
Opening note:
Nicholas Callinan,
Managing Partner,
Shell Internet Ventures

SOFTWARE /ASP
19.00 COCKTAIL RECEPTION
DAY TWO Wednesday 30 January 2002
08.30 Chair Harald Ehren, Inside Business, Financial Times Deutschland
INTRODUCTORY ADDRESS
*
Hans Spitzner,
Vice Minister and State Secretary,
Bavarian Ministry for Economic Affairs, Transport & Technology
08.40

The Great Silicon Valley Swindle
Paul Abrahams, Silicon Valley Bureau Chief, Financial Times

09.00 Venture Capital Landscape in Germany
Dr. Hans-Christian Perle, Investment Director
Ad_Astra Venture Consult GmbH
09.20 The Cambridge Cluster – A Bottom-Up Initiative
Tim Minshall, Member of the Board
St John’s Innovation Centre Ltd
09.40 Trends and Prospects in New Technologies
Dr. Ralf-Dieter Schnell, General Managing Director
Infineon Ventures
10.00 Value Added Services Provided by VCs
Michael Mathiesen, President & CEO, 2M Invest
10.20 Break
10.40
Chair
Ven
Bar
Alta
Tim
Int
Ste
E.ON

11.25

 

 

New Technologies
Chair Holger Heims, Managing Partner,

DVC Deutsche Venture Capital
Barun Dutta, CTO,
Alta Berkeley Venture Partners
Tim Keating, Director,
Intel Capital Europe

Steffen Hasselwander, CEO,
E.ON Venture Partners


Israel as a Technology Innovator
Chair Zeev Holtzman, Board Member,
IVA Israel Venture Association & Founder, Chairman & CEO, Giza Venture Capital
Dr. Eli Carmon, Manager,
KPMG Somekh Chaikin

Chemi Peres, Managing Director & Founder, Pitango Venture Capital
Jon Medved, General Partner & Founder,
Israel Seed Partners

SMALL CAP/ PRE-IPO
Plenary Presentation

Ivy Lindstrom Fredericks
Managing Director of
Corporate Finance
Westminster Securities Corporation
x
x
x
x
x
x

COMPANY
PRESENTATIONS

x
x
x
x

12.10 Investor Panel
Chair Alf Grunwald, Managing Director, Warburg Pincus
Maximilian Brönner, Partner, LGT Capital Partners
Dr. Holger Frommann, Managing Director, BVK
Dr. Ulrich Geilinger, Board Member, HBM Partners AG
13.00 Lunch
14.15
Software Panel
Werner Dreesbach, Senior Principal, Atlas Venture
Dr. Christian Waldvogel, Partner, Viventures Partners
Michael Wand, Director,
Carlyle Europe Venture Partners


SOFTWARE /ASP
NEW TECHNOLOGIES
SECURITY TECHNOLOGIES /
NANOTECHNOLOGY
17.00 Close of Conference
*tbc back to top